View all trials
Are you a member? Sign in above to view additional information
  • Study title
    A Phase 1 study of Temozolomide, Irinotecan, and O6BG for Children with Recurrent or Resistant Neuroblastoma.
  • Protocol ID
    TIO
  • Disease
    Disease Type Disease Subtype
    Solid tumours
    Neuroblastoma
  • Eligibility criteria
  • Study Status
    Open
  • Location(s)
    Children's Hospital at Westmead
    • Centre Study Status:
      Open
    • Notes:
  • Phase
    Phase 1
  • Study type
    Treatment
  • Diagnosis stage
    Relapse/refractory
  • Study open date
    28/07/2014
  • Study close date
    N/A
  • Study chair
  • Sponsor
    Sydney Children's Hospital Network
Back to search results